A guide to 90Y radioembolization and its dosimetry

SP Kim, C Cohalan, N Kopek, SA Enger - Physica Medica, 2019 - Elsevier
Radioembolization gains continuous traction as a primarily palliative radiation treatment for
hepatic tumours. A form of nuclear medicine therapy, Yttrium-90 containing microspheres …

[HTML][HTML] Radioembolization of hepatic lesions from a radiobiology and dosimetric perspective

M Cremonesi, C Chiesa, L Strigari, M Ferrari… - Frontiers in …, 2014 - frontiersin.org
Radioembolization (RE) of liver cancer with 90Y-microspheres has been applied in the last
two decades with notable responses and acceptable toxicity. Two types of microspheres are …

[HTML][HTML] EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds

M Weber, M Lam, C Chiesa, M Konijnenberg… - European journal of …, 2022 - Springer
Primary liver tumours (ie hepatocellular carcinoma (HCC) or intrahepatic
cholangiocarcinoma (ICC)) are among the most frequent cancers worldwide. However, only …

[HTML][HTML] International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin …

H Levillain, O Bagni, CM Deroose, A Dieudonné… - European journal of …, 2021 - Springer
Purpose A multidisciplinary expert panel convened to formulate state-of-the-art
recommendations for optimisation of selective internal radiation therapy (SIRT) with yttrium …

Clinical and dosimetric considerations for Y90: recommendations from an international multidisciplinary working group

R Salem, SA Padia, M Lam, J Bell, C Chiesa… - European journal of …, 2019 - Springer
Abstract The TheraSphere Global Dosimetry Steering Committee was formed in 2017 by
BTG International to review existing data and address gaps in knowledge related to …

[HTML][HTML] Clinical, dosimetric, and reporting considerations for Y-90 glass microspheres in hepatocellular carcinoma: updated 2022 recommendations from an …

R Salem, SA Padia, M Lam, C Chiesa, P Haste… - European Journal of …, 2023 - Springer
Purpose In light of recently published clinical reports and trials, the TheraSphere Global
Dosimetry Steering Committee (DSC) reconvened to review new data and to update …

EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds

F Giammarile, L Bodei, C Chiesa, G Flux… - European journal of …, 2011 - Springer
Primary liver cancers (ie hepatocellular carcinoma or cholangiocarcinoma) are worldwide
some of the most frequent cancers, with rapidly fatal liver failure in a large majority of …

99mTc-macroaggregated albumin poorly predicts the intrahepatic distribution of 90Y resin microspheres in hepatic radioembolization

M Wondergem, MLJ Smits, M Elschot… - Journal of Nuclear …, 2013 - Soc Nuclear Med
In hepatic 90Y radioembolization, pretreatment 99mTc-macroaggregated albumin (99mTc-
MAA) nuclear imaging is used for lung shunt analysis, evaluation of extrahepatic deposition …

Patient selection and activity planning guide for selective internal radiotherapy with yttrium-90 resin microspheres

WY Lau, AS Kennedy, YH Kim, HK Lai, RC Lee… - International Journal of …, 2012 - Elsevier
PURPOSE: Selective internal radiotherapy (SIRT) with yttrium-90 (90Y) resin microspheres
can improve the clinical outcomes for selected patients with inoperable liver cancer. This …

[HTML][HTML] Post-radioembolization yttrium-90 PET/CT-part 2: dose-response and tumor predictive dosimetry for resin microspheres

YH Kao, JD Steinberg, YS Tay, GKY Lim, J Yan… - EJNMMI research, 2013 - Springer
Background Coincidence imaging of low-abundance yttrium-90 (90 Y) internal pair
production by positron emission tomography with integrated computed tomography …